microdosing semaglutide for perimenopause My Story & Clinical Curiosity — Emily Sadri GLP-1 Microdosing During Menopause: Is

But because these effects are dose-dependent, clinical trial data has consistently shown that the frequency and severity of GI side effects are significantly higher at the maximum therapeutic doses compared to the lower, initial titration doses

Also: dont ignore the urge to go

If symptoms persist, your provider may evaluate for interstitial cystitis or other non-infectious urinary conditions

Many people begin to see noticeable weight loss

The medication works by slowing digestion and reducing appetite, making food quality particularly important for sustaining energy, ensuring adequate high-quality protein intake, and preventing nutrient deficiencies